| scholarly article | Q13442814 |
| P356 | DOI | 10.1165/AJRCMB/3.5.413 |
| P698 | PubMed publication ID | 2121170 |
| P2093 | author name string | DeVinney R | |
| Gold WM | |||
| P2860 | cites work | Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores | Q59052484 |
| Growth of a pure population of mouse mast cells in vitro with conditioned medium derived from concanavalin A-stimulated splenocytes | Q24635045 | ||
| Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions | Q34193785 | ||
| Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs | Q34564167 | ||
| Two types of human mast cells that have distinct neutral protease compositions | Q35611922 | ||
| Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines | Q36356540 | ||
| Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells | Q37397453 | ||
| The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression | Q37679722 | ||
| Differentiation and transdifferentiation of mast cells; a unique member of the hematopoietic cell family | Q39765087 | ||
| The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? | Q40087645 | ||
| Prostaglandin, thromboxane, and 12-hydroxy-5,8,10,14-eicosatetraenoic acid production by ionophore-stimulated rat serosal mast cells | Q41129460 | ||
| Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation | Q41463550 | ||
| Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells | Q42800379 | ||
| Histochemical comparison of mast cells obtained from the airways of mongrel dogs and Basenji-Greyhound dogs by bronchoalveolar lavage | Q44721438 | ||
| Chymase and tryptase in dog mastocytoma cells: asynchronous expression as revealed by enzyme cytochemical staining | Q46058275 | ||
| Differential reactivity of isolated mast cells from the rat and guinea pig. | Q46221748 | ||
| Dog mastocytoma tryptase: affinity purification, characterization, and amino-terminal sequence | Q46228377 | ||
| Dog mastocytoma proteoglycans: occurrence of heparin and oversulfated chondroitin sulfates, containing trisulfated disaccharides, in three cell lines | Q46350238 | ||
| Functional and morphologic characterization of mast cells recovered by bronchoalveolar lavage from Basenji greyhound and mongrel dogs | Q46714636 | ||
| An automated continuous-flow system for the extraction and fluorometric analysis of histamine | Q47881145 | ||
| Mast cell heterogeneity in dog skin. | Q50913017 | ||
| An ultrastructural analysis of dog mastocytoma cells and normal mast cells. | Q50915006 | ||
| Mucosal mast cells of the rat intestine: a re-evaluation of fixation and staining properties, with special reference to protein blocking and solubility of the granular glycosaminoglycan. | Q50928790 | ||
| Purification and identification of two serine class proteinases from dog mast biochemically and immunologically similar to human proteinases tryptase and chymase. | Q54400584 | ||
| P4510 | describes a project that uses | C1 | Q54807802 |
| C2 | Q54807886 | ||
| P433 | issue | 5 | |
| P921 | main subject | cell line | Q21014462 |
| P304 | page(s) | 413-420 | |
| P577 | publication date | 1990-11-01 | |
| P1433 | published in | American Journal of Respiratory Cell and Molecular Biology | Q4744268 |
| P1476 | title | Establishment of two dog mastocytoma cell lines in continuous culture | |
| P478 | volume | 3 |
| Q46713890 | Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and up-regulated by stem cell factor |
| Q39670398 | Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours* |
| Q42079944 | Characterization and modulation of canine mast cell derived eicosanoids |
| Q33421041 | Characterization of NVX-207, a novel betulinic acid-derived anti-cancer compound |
| Q38953475 | Combination therapy for KIT-mutant mast cells: targeting constitutive NFAT and KIT activity. |
| Q41029905 | Comparative morphofunctional study of dispersed mature canine cutaneous mast cells and BR cells, a poorly differentiated mast cell line from a dog subcutaneous mastocytoma. |
| Q40188685 | Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. |
| Q33726782 | Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor. |
| Q41717441 | Dipeptidyl peptidase I cleaves matrix-associated proteins and is expressed mainly by mast cells in normal dog airways |
| Q36885449 | Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain |
| Q35603298 | Dog mastocytoma cells produce transforming growth factor beta 1 |
| Q42818911 | Dog mastocytoma cells secrete a growth factor for fibroblasts |
| Q48104415 | Drug-induced inhibition of phosphorylation of STAT5 overrides drug resistance in neoplastic mast cells. |
| Q91732120 | Effects of ibrutinib on proliferation and histamine release in canine neoplastic mast cells |
| Q55433181 | Exploration of serum- and cell culture-derived exosomes from dogs. |
| Q38376182 | Expression of Phosphorylated KIT in Canine Mast Cell Tumor. |
| Q37095268 | Generation and characterization of novel canine malignant mast cell line CL1. |
| Q39689493 | H1-receptor antagonists terfenadine and loratadine inhibit spontaneous growth of neoplastic mast cells |
| Q48120081 | IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells. |
| Q36406996 | Identification of the Ki-1 antigen (CD30) as a novel therapeutic target in systemic mastocytosis. |
| Q37275619 | In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors |
| Q99409940 | In vitro effects of histamine receptor 1 antagonists on proliferation and histamine release in canine neoplastic mast cells |
| Q40685915 | Influence of vitamin E on mast cell mediator release |
| Q40801501 | Molecular cloning of canine IL-13 receptor alpha chain (alpha1 and alpha2) cDNAs and detection of corresponding mRNAs in canine tissues |
| Q39348704 | NI-1: a novel canine mastocytoma model for studying drug resistance and IgER-dependent mast cell activation. |
| Q33979068 | New approaches to therapy for mastocytosis. A case for treatment with kit kinase inhibitors |
| Q39606792 | Polo-like kinase-1 as a novel target in neoplastic mast cells: demonstration of growth-inhibitory effects of small interfering RNA and the Polo-like kinase-1 targeting drug BI 2536. |
| Q35087639 | Preclinical evaluation of the novel, orally bioavailable Selective Inhibitor of Nuclear Export (SINE) KPT-335 in spontaneous canine cancer: results of a phase I study |
| Q32061318 | Regulated expression, processing, and secretion of dog mast cell dipeptidyl peptidase I. |
| Q40959621 | Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit |
| Q40412319 | The Influence of long-chain polyunsaturated fatty acids on total lipid fatty acid composition of a canine mastocytoma cell line |
| Q48291629 | The JAK2/STAT5 signaling pathway as a potential therapeutic target in canine mastocytoma. |
| Q39736210 | The histamine H receptor as a new target for treatment of canine inflammatory skin diseases. |
| Q37974469 | The importance of mouse, rat, and dog mast cell lines |
| Q41900217 | The influence of polyunsaturated fatty acids on the phospholipase D isoforms trafficking and activity in mast cells |
| Q36654416 | The role of mast cells in atopy: what can we learn from canine models? A thorough review of the biology of mast cells in canine and human systems. |
Search more.